Moclobemide Sandoz

Moclobemide, the active ingredient in Moclobemide Sandoz, is a reversible monoamine oxidase A inhibitor (RIMA) presented as an oral formulation for oral use. It is prescribed for the treatment of major depressive disorder in adults.

GNH USA supplies Moclobemide Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moclobemide is a reversible MAO‑A inhibitor used primarily in mood‑related disorders.

- Major depressive disorder: alleviates depressive symptoms and improves mood. - Social anxiety disorder: reduces anxiety and social avoidance. - Persistent depressive disorder (dysthymia): helps sustain long‑term mood stability.

Moclobemide may cause a range of adverse reactions, most of which are mild to moderate.

Common Side Effects: - Nausea - Headache - Insomnia or somnolence - Dizziness - Dry mouth - Constipation

Serious or Rare Side Effects: - Hypertensive crisis, especially with tyramine intake - Serotonin syndrome when combined with other serotonergic agents - Severe liver injury - Agranulocytosis - Psychosis or severe agitation - Stevens‑Johnson syndrome or toxic epidermal necrolysis

Before initiating therapy, clinicians should evaluate patient history and monitor for specific risks.

- Cardiovascular assessment: check blood pressure and heart disease history. - Dietary restrictions: avoid tyramine‑rich foods to prevent hypertensive episodes. - Concomitant serotonergic drugs: monitor for serotonin syndrome. - Psychiatric history: watch for emergence of mania or psychosis. - Liver function: assess baseline hepatic enzymes. - Store at room temperature: keep in the original container, protect from moisture and light.

Moclobemide interacts with several drug classes; some combinations must be avoided, while others require careful monitoring.

Major Interactions (Avoid): - Other monoamine oxidase inhibitors (MAOIs) - Selective serotonin reuptake inhibitors (SSRIs) and serotonin‑norepinephrine reuptake inhibitors (SNRIs) - Tricyclic antidepressants (TCAs) - Sympathomimetic agents (e.g., pseudoephedrine) - Certain antihypertensive agents (risk of excessive hypotension)

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs) - Caffeine‑containing products - Decongestants (e.g., phenylephrine) - Certain antipsychotics (e.g., clozapine) - Herbal supplements with serotonergic activity (e.g., St. John’s wort)